Source: Health Products Regulatory Authority (ZA) Revision Year: 2023 Publisher: PHARMACARE LIMITED, Healthcare Park, Woodlands Drive, Woodmead; 2191
RIDAQ-25 tablets.
RIDAQ-50 tablets.
| Pharmaceutical Form |
|---|
|
RIDAQ-25 is a round flat pale peach tablet with bevelled edges and bisected on one side, with a diameter of 6,5 mm. RIDAQ-50 is a round flat pale peach tablet with bevelled edges and bisected on one side, with a diameter of 8,0 mm. The score line is only to facilitate breaking for ease of swallowing and not to divide into equal doses. |
Each tablet of RIDAQ-25 contains 25 mg of hydrochlorothiazide.
Contains sugar: Lactose monohydrate 48,59 mg.
Each tablet of RIDAQ-50 contains 50 mg hydrochlorothiazide.
Contains sugar: Lactose monohydrate 100,43 mg.
For full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Hydrochlorothiazide |
Hydrochlorothiazide is a diuretic with antihypertensive properties. It acts by inhibiting the renal tubular re-absorption of sodium and chloride ions, which are excreted with an accompanying volume of water. Potassium excretion is also promoted. |
| List of Excipients |
|---|
|
RIDAQ-25: Dye P/B orange, lactose monohydrate, magnesium stearate, microcrystalline cellulose, polysorbate, purified talc, sodium starch glycollate, starch maize. RIDAQ-50: Dye lennon lake yellow (C.I. 15985), lactose monohydrate, magnesium stearate, microcrystalline cellulose, polysorbate, purified talc, sodium starch glycollate, starch maize. |
RIDAQ-25:
14 or 28 tablets are packed in a printed, metallised, low-density polyethylene lay-flat bag and sealed with a lay-flat zip.
500 tablets are packed in a white polypropylene container, together with a white rayon and white foam insert, and sealed with a white low-density polyethylene cap.
RIDAQ-50:
500 tablets are packed in a white polypropylene container, together with a white foam insert, and sealed with a white low-density polyethylene cap.
Not all packs and pack sizes are necessarily marketed.
PHARMACARE LIMITED, Healthcare Park, Woodlands Drive, Woodmead; 2191
RIDAQ-25: M/18.1/35
RIDAQ-50: M/18.1/36
Date of first authorization:
RIDAQ-25: 28 January 1981
RIDAQ-50: 28 January 1981
| Drug | Countries | |
|---|---|---|
| RIDAQ | South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
